Prostate Cancer Research is committed to working with companies, Trusts and Foundations, and individuals that share our values and enthusiasm for enabling high quality medical research and the development of new treatments for advanced prostate cancer.
We are the only charity that focuses solely on the advanced stage of prostate cancer, which causes the majority of prostate cancer deaths and for which treatments are currently limited.
Our vision is to provide a future for men and their families affected by prostate cancer. We are focused on turning hope into reality by taking our innovative research projects from testing in the laboratory to clinical trials in men; essential to developing treatments which mean fewer men will suffer and die from the disease.
Within the next year, we plan to fund a further four new projects, with the potential to create breakthrough treatments for men living with prostate cancer.
Corporate Partnerships
A corporate partnership with PCR will enable your organization to raise awareness of prostate cancer and provide a better outcome for those men diagnosed in the future.
Our scientists are finding innovative solutions to treat the leading cancer killer of men. We are looking for future-looking companies to take this journey with us and be at the forefront of breakthroughs in new treatments.
To find out more about how your organization can get involved, whether that be through raising funds, providing support, or funding a research project, please contact Boris Cooper at [email protected].
Trusts and Foundations
Trusts and Foundations are crucial in supporting and funding both existing and new projects.
By partnering with Prostate Cancer Research through a donation or grant, you can help us to significantly increase our impact and develop life-changing treatments for advanced prostate cancer.
If you are interested in our work with Trusts and Foundations, please contact Boris Cooper at [email protected].
If you want to find out more about how you can partner with us, please get in touch.